Unlock instant, AI-driven research and patent intelligence for your innovation.

Neurocyte protective agent

A nerve cell protection, central nervous system technology, applied in nervous system diseases, material inspection products, cardiovascular system diseases, etc.

Inactive Publication Date: 2006-07-12
EISIA R&D MANAGEMENT CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, data demonstrating the protective effect of donepezil hydrochloride against ischemic injury in actual neurons is not known

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Neurocyte protective agent
  • Neurocyte protective agent
  • Neurocyte protective agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0277] Embodiment 1: OGD test

[0278] In this example, a model in which ischemia-like cell damage was induced by applying a load to rat primary cultured cerebral cortical neurons by oxygen-glucose deprivation was used. To study whether donepezil hydrochloride has neuronal protective effect on the above-mentioned ischemic injury.

[0279]In this example, the primary cultured nerve cells were obtained from the cerebral cortex of rat fetuses (17-19 days old viviparous). The culture medium used contained 10% fetal bovine serum (Gibco BRL), 10% horse serum (Gibco BRL), 5 μg / mL insulin (Sigma), 30 nM sodium selenite (Sigma), 100 μM putrescine in DMEM (Gibco BRL). (Sigma), 20 nM progesterone (Sigma), 15 nM biotin (Sigma), 100 units / mL penicillin (GibcoBRL), 100 μg / mL streptomycin (Gibco BRL), 8 mM glucose and 1 mM pyruvate (Sigma) (reference Scholtz et al., 1988), the cells were cultured at 37°C and 5% CO2. After culturing for 7 days or more, OGD treatment was performed. OGD tre...

Embodiment 2

[0288] Embodiment 2: excitotoxicity test

[0289] In this example, the cytoprotective effect of donepezil against NMDA toxicity was investigated. A model in which NMDA stimulation was applied to primary cultured rat cerebral cortex neurons to induce cell damage was used. 100 μM NMDA was added to the rat primary cultured neurons obtained as in Example 1, and the amount of LDH present in the culture solution was measured 9 hours later.

[0290] In this example, the primary cultured nerve cells were obtained from the cerebral cortex of rat fetuses (17-19 days old viviparous). As a culture solution, glucose (1 g / L), penicillin / streptomycin (100 units / mL), and 10% FCS were added to MEM (manufactured by Invitrogen). Media exchange was performed every 2-3 days. When expressing KA toxicity, a neurobasal medium (manufactured by Invitrogen) supplemented with B-27 and 0.25 mM glutamine was used as the medium. Cells at 37°C, 5% CO 2 cultivated in the environment. After culturing for...

Embodiment 3

[0292] Embodiment 3: excitotoxicity test

[0293] Kainic acid is known to enhance nerve cell death induced by β-amyloid (Aβ), which is one of the causative factors of Alzheimer's disease. In Examples, a model in which cell damage was induced by administering kainic acid to primary cultured rat cerebral cortical neurons was used.

[0294] In this example, the primary cultured nerve cells were obtained from the cerebral cortex of rat fetuses (17-19 days old viviparous). cells at 37°C, 5% CO 2 cultivated in the environment. After culturing for more than 7 days, add NMDA or kainic acid to the culture medium, at 37°C, 5% CO 2 Incubate overnight. Donepezil was added to the cells 24 hours before the application of kainic acid stimulation. Then, the amount of LDH present in the culture solution was measured 24 hours after the addition of kainic acid as an index of neuroprotective effect.

[0295] The results of this example are as Figure 6 shown. Depend on Figure 6 It was f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A protective agent for central nerve neurocytes, or preventive and / or therapeutic agent for central nerve system neurocyte disorder, comprising a compound whose representative is donepezil hydrochloride.

Description

technical field [0001] The present invention relates to a nerve cell protective agent containing donepezil hydrochloride. Background technique [0002] Donepezil hydrochloride is a substance that increases the amount of acetylcholine in the brain and activates the cholinergic nervous system in the brain by reversibly inhibiting the enzyme acetylcholinesterase that decomposes acetylcholine. This substance is widely used as a therapeutic drug for Alzheimer's type senile dementia and Alzheimer's disease (Japanese Patent No. 2578475), and donepezil hydrochloride is being studied by various research institutes. Jin Zhou etc. have published the paper that acetylcholinesterase inhibitor has protective effect on ischemic cell injury of rat PC12 cells (tumor cells), using donepezil hydrochloride as an example of acetylcholinesterase inhibitor (Zhou, J, .Fu, Y., Tang, X.C., 2001. Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation. Neurosci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/445A61P25/00G01N33/50C07D211/32
CPCC07D211/32A61K31/445A61P9/10A61P25/00A61P25/28A61K31/4465
Inventor 赤祖父盛木村真奈美
Owner EISIA R&D MANAGEMENT CO LTD